→Appendix 1: HIV-protease inhibitors
PDF page 718
▶Common or very common Back pain. concentration
impaired. confusion. cough. dehydration. feeling hot.
flushing. gastrointestinal haemorrhage. gout.
hypotension. menorrhagia. myopathy. oedema. oral
paraesthesia. oropharyngeal pain. paraesthesia.
peripheral coldness. pharyngitis. renal impairment.
syncope. thrombocytopenia. urinary frequency increased.
vision blurred
▶Uncommon Myocardial infarction
▶Rare or very rare Hyperglycaemia. toxic epidermal
necrolysis
SIDE-EFFECTS, FURTHER INFORMATION Signs and
symptoms suggestive of pancreatitis (including raised
serum lipase) should be evaluated — discontinue if
pancreatitis diagnosed.
PDF page 718
Dose adjustments Only use low-dose booster to increase
the effect of other protease inhibitors.
PDF page 718
When used as a low-dose booster,
manufacturer advises caution in severe impairment; avoid
in decompensated liver disease. When used in high-doses,
manufacturer advises avoid in severe impairment.
Dose adjustments Manufacturer advises consult product
literature of co-administered protease inhibitor.
PDF pages 718, 719